Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus

被引：57

作者：

Fujii A.M. ^{[1
]}

Brown E. ^{[1
]}

Mirochnick M. ^{[1
]}

O'Brien S. ^{[1
]}

Kaufman G. ^{[1
]}

机构：

[1] Department of Pediatrics, Boston Medical Center, Boston, MA 02118, One Boston Medical Center Place

来源：

Journal of Perinatology | 2002年 / 22卷 / 7期

关键词：

D O I：

10.1038/sj.jp.7210795

中图分类号：

学科分类号：

摘要：

Survival of extremely premature infants ( <27 weeks' gestational age) has improved over the past two decades. Indomethacin prophylaxis was used in these infants, who have the highest mortality and morbidity rates, to reduce the incidence of intraventricular hemorrhage and patent ductus arteriosus (PDA). Medical records of 65 extremely premature infants born at our institution between 1995 and 2001 were reviewed retrospectively to determine whether treatment of PDA with indomethacin in the first 48 hours of life reduces the need for PDA ligation or increase neonatal morbidity, when compared to treatment begun later. Thirty infants in the early treatment group (ETG) were treated during the first 48 hours after birth, and 32 infants in the standard treatment group (STG) were managed expectantly for PDA. Three infants died in the first hours of life and were eliminated from further analysis. ETG infants were 24.9±11.1 (mean±SD) weeks' gestation with a birth weight of 678±143 g. STG infants were 25.3±1.1 weeks (NS) ad 730±125 g (NS). Hemodynamically significant PDA was diagnosed or confirmed by echocardiography in ETG patients and 17 STG patients. Of the patients with hemodynamically significant PDA, 1 (5%) ETG and 6 (35%) STG patients underwent surgical ligation (p=0.033). Necrotizing enterocolitis (NEC) with intestinal perforation was the most serious morbidity and occurred in 20% of infants in the ETG, but in no STG infant (p=0.011). Four of the six infants in the ETG with NEC and intestinal perforation died. The overall mortality rate for all infants studied was 28%. We conclude that in extremely premature infants, use of indomethacin during the first 48 hours of life was associated with a reduced need for PDA ligation, but an increased risk of NEC with intestinal perforation.

引用

页码：535 / 540

页数：5

共 30 条

[1]

Ment L.R., Oh W., Ehrendranz R.A., Et al., Low-dose indomethacin and prevention of intraventricular hemorrhage: A multicenter randomized trial, Pediatrics, 93, pp. 543-550, (1994)

[2]

Couser R.J., Ferrara T.B., Wright G.B., Et al., Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactic with surfactant in the delivery room, J. Pediatr, 128, pp. 631-637, (1996)

[3]

Fowlie P.W., Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants, 1, (2001)

[4]

Van Overmeire B., Van de Broek H., Van Laer P., Weyler J., Vanhaesebrouck P., Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome, J. Pediatr, 138, pp. 205-211, (2001)

[5]

Young T.E., Mangum O.B., A Manual of Drugs Used in Neonatal Care, (1994)

[6]

Su B.H., Peng C.T., Tsai C.H., Echocardiographic flow patten of patent ductus arteriosus: A guide to indomethacin treatment in premature infants, Arch. Dis. Child Fetal Neonatal. Ed, 81, (1999)

[7]

Papile L.A., Burstein J., Burstein R., Koffler H., Incidence and evaluation of the subependymal intraventricular hemorrhage: A study of infants with weights less than 1500 g, J. Pediatr, 92, pp. 529-534, (1978)

[8]

Patz A., An international classification of retinopathy of prematurity, Pediatrics, 74, pp. 160-161, (1984)

[9]

Patz A., The international committee for the classification of the late stages of retinopathy of prematurity. An international classification of retinopathy of prematurity: II. The classification of retinal detachment, Arch. Ophthalmol, 105, pp. 906-912, (1987)

[10]

Barton L., Siassi B., Acherman R., Ramanatha R., Low dose indomethacin for patent ductus arteriosus in extremely low birth weight infants, Pediatr. Res, (2001)

← 1 2 3 →